Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board Pharmaceutical Investing
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate Life Science Investing News
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders Pharmaceutical Investing
Knight to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference Pharmaceutical Investing
CLASS ACTION UPDATE for AI, AUPH and LILM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
LAWSUITS FILED AGAINST AFRM, AKBA and ABBV - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
TOP RANKED ROSEN LAW FIRM Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, IBM and IRNT Pharmaceutical Investing
AUPH SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Veklury® is First and Only Approved Treatment for Pediatric Patients Under 12 Years of Age with COVID-19 Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ERIC, AI and ABBV Pharmaceutical Investing
